Log in to save to my catalogue

CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabol...

CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabol...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ee4d73e8c2ab48c68bc10be1ac025155

CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabolism alteration

About this item

Full title

CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabolism alteration

Publisher

England: BioMed Central

Journal title

Biology direct, 2024-05, Vol.19 (1), p.36-36, Article 36

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Epidermal growth factor receptor (EGFR)-targeted therapy is an important treatment for RAS wild-type metastatic colorectal cancer (mCRC), but the resistance mechanism remains unclear. Here, the differential expression of circRNAs between Cetuximab sensitive and resistant cell lines was analyzed using whole-transcriptome sequencing. We identified th...

Alternative Titles

Full title

CircHIF1A induces cetuximab resistance in colorectal cancer by promoting HIF1α-mediated glycometabolism alteration

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ee4d73e8c2ab48c68bc10be1ac025155

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ee4d73e8c2ab48c68bc10be1ac025155

Other Identifiers

ISSN

1745-6150

E-ISSN

1745-6150

DOI

10.1186/s13062-024-00478-x

How to access this item